|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.980 USD | +8.14% |
|
+11.36% | +98.67% |
| 06-29 | Aclaris Therapeutics, Inc.(NasdaqGS:ACRS) added to Russell Small Cap Comp Growth Benchmark | CI |
| 06-29 | Aclaris Therapeutics, Inc.(NasdaqGS:ACRS) added to Russell 2500 Growth Benchmark | CI |
| Market Cap | 835M 724M 676M 621M 1.17B 79.65B 1.19B 7.95B 3.11B 39.72B 3.14B 3.07B 132B | P/E 2026 * |
-9.21x | P/E 2027 * | -7.51x |
|---|---|---|---|---|---|
| Enterprise Value | 700M 607M 566M 520M 984M 66.72B 993M 6.66B 2.6B 33.27B 2.63B 2.57B 110B | EV / Sales 2026 * |
122x | EV / Sales 2027 * | 133x |
| Free-Float |
97.72% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Aclaris Therapeutics, Inc.
| 1 day | +8.14% | ||
| 1 week | +11.36% | ||
| Current month | +15.00% | ||
| 1 month | +7.55% | ||
| 3 months | +35.60% | ||
| 6 months | +72.33% | ||
| Current year | +98.67% |
| 1 week | 5.01 |  | 6.04 |
| 1 month | 5.01 | | 6.04 |
| Current year | 2.49 | | 6.04 |
| 1 year | 1.52 | | 6.04 |
| 3 years | 0.59 | | 9.95 |
| 5 years | 0.59 | | 19.97 |
| 10 years | 0.59 | | 33.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Neal Walker
CEO | Chief Executive Officer | 56 | 2024-01-16 |
Hugh Davis
PSD | President | 67 | 2024-11-17 |
Kevin Balthaser
DFI | Director of Finance/CFO | 39 | 2022-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Neal Walker
CHM | Chairman | 56 | 2022-12-31 |
Anand Mehra
BRD | Director/Board Member | 50 | 2014-08-31 |
| Director/Board Member | 59 | 2016-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/1/26 | Fiscal year | Chief Financial Officer | 5,427 | 0.0050% | ||
| 2/3/26 | Fiscal year | Executive/Senior Manager | 47,687 | 0.0440% | ||
| 2/3/26 | Fiscal year | Chief Financial Officer | 50,499 | 0.0466% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +8.14% | +11.36% | +290.85% | -39.17% | 772M | |
| +10.00% | +13.39% | +51.99% | +83.45% | 56.7B | |
| +0.80% | -7.82% | +24.61% | +60.00% | 51.97B | |
| -0.98% | +0.29% | -14.90% | -14.35% | 23.33B | |
| +0.30% | -5.71% | -9.15% | +345.82% | 21.34B | |
| +1.73% | -1.57% | +35.40% | -28.62% | 17.44B | |
| +4.29% | +1.67% | +201.24% | +344.48% | 14.77B | |
| +1.71% | +0.34% | +50.30% | +169.75% | 13.84B | |
| +4.16% | +4.75% | +462.40% | +177.20% | 12.12B | |
| +5.30% | -7.93% | +67.97% | +162.62% | 11.14B | |
| Average | +3.54% | -0.27% | +116.07% | +126.12% | 22.34B | |
| Weighted average by Cap. | +3.69% | +0.45% | +65.15% | +115.31% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.71M 4.95M 4.62M 4.25M 8.03M 545M 8.11M 54.35M 21.27M 272M 21.45M 20.98M 901M | 5.36M 4.65M 4.34M 3.98M 7.53M 511M 7.6M 50.98M 19.95M 255M 20.12M 19.68M 845M |
| Net income | -84.78M -73.52M -68.62M -63.03M -119M -8.09B -120M -807M -316M -4.03B -318M -311M -13.38B | -103M -88.9M -82.97M -76.21M -144M -9.78B -145M -975M -382M -4.87B -385M -376M -16.17B |
| Net Debt | -136M -118M -110M -101M -191M -12.93B -192M -1.29B -505M -6.45B -509M -498M -21.39B | -125M -108M -101M -92.86M -176M -11.91B -177M -1.19B -465M -5.94B -469M -459M -19.71B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-04 | US$5.980 | +8.14% | 2,573,633 |
| 26-08-03 | US$5.530 | +6.35% | 1,952,023 |
| 26-07-31 | US$5.200 | -2.26% | 1,638,335 |
| 26-07-30 | US$5.320 | +3.91% | 1,905,224 |
| 26-07-29 | US$5.120 | -3.94% | 1,177,994 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ACRS Stock
Select your edition
All financial news and data tailored to specific country editions
